ICD-10-CM 2027 diagnosis code
Z79.6Long term (current) use of immunomodulators and immunosuppressants
Z79.6 is a header code, so it can't be reported by itself. Choose one of the 6 more specific codes beneath it.Short description: Long term (crnt) use of immunomodulator & immunosuppressant
Code last changed in FY2023 (effective October 1, 2022). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About Z79.6
Z79.6 is the ICD-10-CM diagnosis code for long term (current) use of immunomodulators and immunosuppressants. It belongs to category Z79 (long term (current) drug therapy), block Z77-Z99 (persons with potential health hazards related to family and personal history and certain conditions influencing health status) and chapter 21 (factors influencing health status and contact with health services). It is a header code, so it can't be reported by itself; one of its 6 subcodes must be used instead.
Within Z79 (long term (current) drug therapy), Z79.6 is specifically for long term (current) use of immunomodulators and immunosuppressants. Related codes cover long term (current) use of anticoagulants and antithrombotics/antiplatelets (Z79.0), long term (current) use of non-steroidal anti-inflammatories (NSAID) (Z79.1), long term (current) use of antibiotics (Z79.2), long term (current) use of hormonal contraceptives (Z79.3), long term (current) use of insulin (Z79.4), long term (current) use of steroids (Z79.5) and other long term (current) drug therapy (Z79.8).
To report this condition, pick the subcode that matches the documentation: Z79.60 (immunosuppressants), Z79.61 (immunomodulator), Z79.62 (immunosuppressant), Z79.63 (agent), Z79.64 (agent) and Z79.69 (immunosuppressants).
The conditions in its Excludes2 note aren't part of Z79.6, but may be coded alongside it if the patient has both: long term (current) use of steroids (Z79.5-) and long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-).
It was added in FY2023, effective October 1, 2022.
Specific codes under Z79.6
- Z79.60Long term (current) use of unspecified immunomodulators and immunosuppressantsBillable
- Z79.61Long term (current) use of immunomodulatorBillable
- Z79.62Long term (current) use of immunosuppressant
- Z79.620Long term (current) use of immunosuppressive biologicBillable
- Z79.621Long term (current) use of calcineurin inhibitorBillable
- Z79.622Long term (current) use of Janus kinase inhibitorBillable
- Z79.623Long term (current) use of mammalian target of rapamycin (mTOR) inhibitorBillable
- Z79.624Long term (current) use of inhibitors of nucleotide synthesisBillable
- Z79.63Long term (current) use of chemotherapeutic agent
- Z79.630Long term (current) use of alkylating agentBillable
- Z79.631Long term (current) use of antimetabolite agentBillable
- Z79.632Long term (current) use of antitumor antibioticBillable
- Z79.633Long term (current) use of mitotic inhibitorBillable
- Z79.634Long term (current) use of topoisomerase inhibitorBillable
- Z79.64Long term (current) use of myelosuppressive agentBillable
- Z79.69Long term (current) use of other immunomodulators and immunosuppressantsBillable
Coding notes
Notes that apply from higher levels
Instructions written at a parent level also apply to Z79.6.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2023 (effective 10/1/2022): Added
- No changes since FY2023.
Common questions about Z79.6
Is Z79.6 billable?
- No. Z79.6 is a header code. Report one of its more specific subcodes instead.